Not sure where to start? Try searching for your diagnosis above or visit the "Conditions" section.
Curated scientific studies about autoimmune diseases.
This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer
A new antibody called bempikibart produced meaningful hair regrowth in a small trial of adults with severe alopecia areata, including some p...
Read More — Experimental Antibody Shows Durable Hair Regrowth in Severe Alopecia Areata Trial »Q32 Bio's bempikibart helped 40% of severe alopecia areata patients regrow enough hair to cover most of the scalp by week 36, offering a pot...
Read More — Bempikibart Shows Durable Hair Regrowth in Severe Alopecia Areata »Ipsen's elafibranor (Iqirvo) normalized a key liver enzyme in 85% of primary biliary cholangitis patients with milder disease in a new phase...
Read More — PBC Liver Drug Nearly Doubles Its Potential Patient Pool in New Trial »Scientists presented early results from a first-in-human trial testing whether engineered, lab-grown insulin-producing cells can survive in...
Read More — First-in-Human Trial Tests Immune-Engineered Cells for Type 1 Diabetes Without Lifelong Immunosuppression »A first-in-human study presented at ISSCR 2026 tests whether genetically engineered insulin-producing cells can survive in the body without...
Read More — A New Approach to Diabetes Cell Therapy Skips the Immunosuppression Problem »Aurinia Pharmaceuticals has launched a new study testing whether pairing its approved lupus nephritis drug with one of three newer biologics...
Read More — A Combination Approach to the Toughest Lupus Kidney Cases »Researchers identified a lipid metabolism pathway involving a protein called macrophage INSIG1 that appears strongly linked to psoriasis, in...
Read More — A Lipid Clue in Psoriasis »A sweeping New England Journal of Medicine review pulls together what's been learned about multiple sclerosis mechanisms, biomarkers, and tr...
Read More — A Checkpoint on Where MS Science Actually Stands »Abivax's oral pill obefazimod helped more than a third of ulcerative colitis patients who failed initial treatment reach clinical remission...
Read More — Oral Drug Helps Hard-to-Treat Ulcerative Colitis Patients Reach Remission »Abivax's oral pill obefazimod helped more than a third of ulcerative colitis patients who hadn't responded to initial treatment reach remiss...
Read More — A Gut Drug Pulls Refractory Ulcerative Colitis Patients Back Into Remission »A randomized trial found that abatacept cut the risk of developing full-blown rheumatoid arthritis by more than half compared to standard hy...
Read More — Could Rheumatoid Arthritis Be Preventable in Some People? »Merck's tulisokibart became the first anti-TL1A antibody to succeed in a phase 3 trial, helping ulcerative colitis patients reach clinical r...
Read More — First Anti-TL1A Drug Hits Its Mark in Ulcerative Colitis »